|
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Association analysis identifies ZNF750 regulatory variants in psoriasis.
|
22185198 |
2011 |
|
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein.
|
16751772 |
2006 |
|
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein.
|
16751772 |
2006 |
|
Seborrhea-Like Dermatitis with Psoriasiform Elements
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Seborrheic dermatitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Hyperkeratosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Hyperkeratosis, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
Zinc-finger protein 750 (ZNF750) is a potential tumor suppressor in oral squamous cell carcinoma (OSCC).
|
31545271 |
2019 |
|
Squamous cell carcinoma of esophagus
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
This study also found that 44/106(4151%), 37/106 (34.91%), 39/106(36.79%) of ESCC showed heterogeneous expression of ZNF750, EP300 and MTOR respectively by IHC, 8/12(66.67%), 8/12(66.67%), 4/12(33.33%), 4/12(33.33%) of ZNF750, EP300, MTOR and KMT2D respectively by RNAscope, IHC and RNAscope could successfully detect a high prevalence of ITH.
|
30528923 |
2019 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
ZNF750 could modulate the tumor vascular microenvironment to inhibit the oral squamous cells carcinoma malignant progression.
|
29890464 |
2018 |
|
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
ZNF750, a transcriptional regulator of epidermal differentiation, has been identified as a tumor suppressor in esophageal squamous cell carcinoma (ESCC).
|
29216641 |
2018 |
|
Squamous cell carcinoma of esophagus
|
0.060 |
Biomarker
|
disease |
BEFREE |
The low expression of ZNF750 was significantly associated with a poor prognosis, and ZNF750 expression may, therefore, be a reliable prognostic biomarker in ESCC.
|
29216641 |
2018 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
|
27819679 |
2017 |
|
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
|
29113187 |
2017 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
ZNF750, an epidermal differentiation regulator, has been suggested to act as a tumor suppressor of esophageal squamous cell carcinoma (ESCC).
|
28558382 |
2017 |
|
Squamous cell carcinoma of esophagus
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
The aim of the present study was to evaluate the relationship between ZNF750 expression and response to CRT in ESCC.
|
28558382 |
2017 |
|
Squamous cell carcinoma of esophagus
|
0.060 |
Biomarker
|
disease |
BEFREE |
The present authors previously identified a novel candidate tumor suppressor gene, zinc finger protein 750 (<i>ZNF750</i>), in esophageal squamous cell carcinoma (ESCC) (1).
|
28789412 |
2017 |
|
Squamous cell carcinoma of esophagus
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Combined analysis from current and previous genomic ESCC studies indicated more frequent ZNF750 mutation in diagnosed cases with LN metastasis than in those without metastasis (14% versus 3.4%, n = 629, P = 1.78 × 10<sup>-5</sup> ).
|
28608921 |
2017 |
|
Squamous cell carcinoma of esophagus
|
0.060 |
Biomarker
|
disease |
BEFREE |
Functional analyses suggest roles for several genes (CBX4, CBX8, AJUBA, and ZNF750) in ESCC.
|
25839328 |
2015 |
|
Squamous cell carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment.
|
29890464 |
2018 |
|
Squamous cell carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
The expression level of ZNF750 in tissue specimens from OSCC patients was detected by immunohistochemistry.
|
29416636 |
2018 |
|
Squamous cell carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.
|
29113187 |
2017 |
|
Squamous cell carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
|
27819679 |
2017 |
|
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
The present study is to explore the mechanism of ZNF750 to suppress the tumor malignant process by regulation tumor microenvironment.
|
29890464 |
2018 |
|
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Zinc-finger protein 750 (ZNF750) is the potential anti-cancer gene in oral squamous cell carcinoma (OSCC).
|
29416636 |
2018 |